The notion that effects on p53 differ with cellular context is emphasized by the fact that in MDM2-amplified liposarcoma cells, HDAC inhibition resulted in the downregulation of p53 irrespective of its mutational status, whereas in cancer cells without MDM2 alteration no effect on p53 expression was observed [97]. Here, HDAC9 is linked to cancer.